◄ back to all posts

BMY: Bristol-Myers Squibb Co. Stock

Written by | Jul 6, 2018

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 142,662.59
Enterprise Value ($M) 170,503.69
Book Value ($M) 50,158.00
Book Value / Share 22.20
Price / Book 2.83
NCAV ($M) -41,029.00
NCAV / Share -18.16
Price / NCAV -3.46

Profitability (mra)
Return on Invested Capital (ROIC) 0.03
Return on Assets (ROA) 0.10
Return on Equity (ROE) 0.25

Liquidity (mrq)
Quick Ratio 1.58
Current Ratio 1.67

Balance Sheet (mrq) ($M)
Current Assets 34,277.00
Assets 125,536.00
Liabilities 75,306.00
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 26,145.00
Operating Income n/a
Net Income 3,460.00
Earnings Per Share Diluted 2.01
Earnings Per Share Basic 2.02

Cash Flow Statement (mra) ($M)
Cash From Operations 8,067.00
Cash from Investing -9,770.00
Cash from Financing -9,770.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
2020-02-12 13G/A Vanguard Group Inc 8.32 47.96
2020-02-05 13G/A BlackRock Inc. 7.30 48.26
2020-01-28 13G/A Wellington Management Group Llp 3.57 -31.10
2015-02-13 13G/A Capital World Investors 4.30

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2020-11-05 10-Q September 30, 2020
2020-08-06 10-Q June 30, 2020
2020-05-07 10-Q March 31, 2020
2020-02-24 10-K December 31, 2019

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2020-11-27 409,367 4,165,922 9.83
2020-11-25 820,260 9,520,900 8.62
2020-11-24 1,279,716 13,235,941 9.67
2020-11-23 894,684 9,595,900 9.32

(click for more detail)

(click for list of largest short owners)

Similar Companies
AMRX – Amneal Pharmaceuticals, Inc. BHS – Bausch Health Companies
BHVN – Biohaven Pharmaceutical Holding BXLT – Baxalta Incorporated
CBM – Cambrex Corp.


Financial data and stock pages provided by
Fintel.io




2018/07/06
◄ back to all posts

Retirement